Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia

  • Tohru Minamino
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • Helen Christou
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • Chung-Ming Hsieh
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • Yuxiang Liu
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • Vijender Dhawan
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • Nader G. Abraham
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • Mark A. Perrella
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • S. Alex Mitsialis
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595
  • Stella Kourembanas
    Department of Medicine, Division of Newborn Medicine, Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA 02115; Program of Developmental Cardiovascular Biology, the Cardiovascular Division and the Pulmonary and Critical Care Division, Brigham & Women's Hospital, Boston, MA 02115; and Department of Pharmacology, New York Medical College, Valhalla, NY 10595

書誌事項

公開日
2001-07-10
DOI
  • 10.1073/pnas.161272598
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p>Chronic hypoxia causes pulmonary hypertension with smooth muscle cell proliferation and matrix deposition in the wall of the pulmonary arterioles. We demonstrate here that hypoxia also induces a pronounced inflammation in the lung before the structural changes of the vessel wall. The proinflammatory action of hypoxia is mediated by the induction of distinct cytokines and chemokines and is independent of tumor necrosis factor-α signaling. We have previously proposed a crucial role for heme oxygenase-1 (HO-1) in protecting cardiomyocytes from hypoxic stress, and potent anti-inflammatory properties of HO-1 have been reported in models of tissue injury. We thus established transgenic mice that constitutively express HO-1 in the lung and exposed them to chronic hypoxia. HO-1 transgenic mice were protected from the development of both pulmonary inflammation as well as hypertension and vessel wall hypertrophy induced by hypoxia. Significantly, the hypoxic induction of proinflammatory cytokines and chemokines was suppressed in HO-1 transgenic mice. Our findings suggest an important protective function of enzymatic products of HO-1 activity as inhibitors of hypoxia-induced vasoconstrictive and proinflammatory pathways.</jats:p>

収録刊行物

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ